Cleared Traditional

K132031 - AFINION LIPID PANEL AND AFINION LIPID P...

K132031 is the FDA 510(k) clearance for AFINION LIPID PANEL AND AFINION LIPID P... by Axis-Shield Poc AS. It is a Class 1 Chemistry device (product code CHH) cleared through the Traditional 510(k) pathway after a 246-day FDA review.

K132031 · Axis-Shield Poc AS · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2014
Decision
246d
Days
Class 1
Risk

K132031 is an FDA 510(k) clearance for the AFINION LIPID PANEL AND AFINION LIPID PANEL CONTROL. Classified as Enzymatic Esterase--oxidase, Cholesterol (product code CHH), Class I - General Controls.

Submitted by Axis-Shield Poc AS (Oslo, NO). The FDA issued a Cleared decision on March 21, 2014 after a review of 246 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1175 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Axis-Shield Poc AS devices

Submission Details

510(k) Number K132031 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 18, 2013
Decision Date March 21, 2014
Days to Decision 246 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
158d slower than avg
Panel avg: 88d · This submission: 246d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code CHH Enzymatic Esterase--oxidase, Cholesterol
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1175
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CHH Enzymatic Esterase--oxidase, Cholesterol

All 122
Devices cleared under the same product code (CHH) and FDA review panel - the closest regulatory comparables to K132031.
Mission Lipid Panel Monitoring System
K180504 · ACON Laboratories, Inc. · Mar 2018
Mission Cholesterol Monitoring System, Mission Cholesterol Pro Monitoring System
K163406 · ACON Laboratories, Inc. · Jul 2017
Cholesterol
K150654 · Randox Laboratories, Ltd. · Sep 2015
EASYRA CHOLESTEROL REAGENT
K072249 · Medica Corp. · Feb 2008
ACCUCHEK INSTANT PLUS DUAL TESTING SYSTEM, ACCUCHEK INSTANT PLUS CHOLESTEROL, ACCUCHEK INSTANT PLUS GLUCOCOSE
K051376 · Roche Diagnostics · Aug 2005
COBAS INTEGRA CHOLESTEROL GEN. 2
K031824 · Roche Diagnostics Corp. · Jul 2003